Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: Initial results

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 4, 1998, Pages 783-788

  Hawighorst, Hans ^a   Knopp, Michael V ^a   Debus, Jürgen ^b   Hoffmann, Ulf ^a   Grandy, Martin ^a   Griebel, Jürgen ^c   Zuna, Ivan ^a   Essig, Marco ^a   Schoenberg, Stefan O ^a   DeVries, Alexander ^d   Brix, G ^a   Van Kaick, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Malignant glioma; MR, pharmacokinetic modeling; Stereotactic radiotherapy

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTRAST ENHANCEMENT; DOSE TIME EFFECT RELATION; FEMALE; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEREOTAXIS; TREATMENT OUTCOME; TUMOR VOLUME;

BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; STEREOTAXIC TECHNIQUES;

EID: 0031875602     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080406     Document Type: Article

References (22)

1. Jain R. Barriers to drug delivery in solid tumors. Sci Am 1994; 58-65.
2. Peters L, Brock W, Chapman J, Wilson G, Fowler J. Predictive assay of tumor radiocurability. Am J Clin Oncol 1988; 11:275-287.
3. Gray LH, Conger AD, Ebert M. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26:638-648.
4. Höckel M, Schlenger K, Billur A, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56:4509-4515.
5. Vaupel P, Fortmeyer H, Runkel S, Kallinowski F. Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 1987; 47:3496-3503.
6. Beanay RP, Lammertsma AA, Jones T, McKenzie CG, Halnan KE. Positron emission tomography for in vivo measurement of regional blood flow, oxygen utilization and blood volume in patients with breast carcinoma. Lancet 1984; 1:131-134.
7. Urtasan RC, Chapman JD, Raleigh JA, Franko AJ, Koch CJ. Binding of H-3-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys 1986; 12; 1263-1267.
8. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J. Dynamic studies of gadolinium uptake in tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992; 26:241-258.
9. Kremser C, Gneiting T, deVries A, et al. Ultrafast T1 mapping on a whole body scanner: a new method for the quantification of dynamic contrast agent studies in patients with malignant neoplasms: In: Proceedings of the 81st annual scientific meeting of the Radiological Society of North America. Chicago: Radiological Society of North America, 1995; 197(P):390.
10. Koenig H, Sieper J, Wolf KJ. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with enhanced dynamic MR imaging. Radiology 1990; 176:473-477.
11. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621-627.
12. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR-mammography. Magn Reson Med 1995; 33:506-514.
13. Hawighorst H, Knapstein PG, Weikel W, et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996; 201:531-539.
14. Nägele T, Petersen D, Klose U, et al. Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging. Am J Neuroradiol 1993; 14:89-98.
15. Griebel J, Mayr NA, de Vries A, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. JMRI 1997; 7:111-119.
16. Hawighorst H, Engenhart R, Knopp MV, et al. Intracranial meningiomas: time and dose dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging 1997; 15:423-432.
17. Wenz F, Rempp K, Hess T, et al. Effect of radiation therapy on blood volume in low-grade astrocytomas and normal brain tissue. Am J Roentgenol 1996; 166:187-193.
18. Berkmann RA, Merrill MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91:153-159.
19. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillspie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol 1993; 4:131-133.
20. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994; 59: 520-529.
21. Deen S, Ball RY. Basement membrane and extracellular interstitial matrix components in bladder neoplasia- evidence of angiogenesis. Histopathology 1994; 25:475-481.
22. Nagy JA. Brown LF, Senger DR, Lanir N, Van de Walter L, Dvorak AM. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989; 948:305-324.